Decentralized Trial Technology Resources
-
Setting Up An eCOA Trial In A DCT Context: What You Should Know
8/14/2023
Consider these three aspects when choosing an electronic Clinical Outcome Assessments (eCOA) provider and preparing to set up an eCOA clinical trial.
-
Standardize Vaccine Study Launch Timelines To Just 5 Weeks
10/30/2023
Uncover the pre-built vaccine trial solution that delivers quality and predictability for your entire immunology portfolio.
-
Televisits In Clinical Trials: Why Integrate A Telemedicine Feature In Your eCOA Trials?
4/25/2022
If remote visits are planned in both decentralized and hybrid trials, how precisely do the televisits work and how beneficial can this really be to study patients, site staff, and sponsors?
-
Addressing The Specific Complexities Of Oncology eCOA Clinical Trials
4/18/2022
What are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.
-
The Future Of EDC Systems
5/19/2023
Gain insight from EDC users in sponsor organizations and CROs regarding anticipated trends in the next two years and how EDC systems can align with decentralized clinical trials.
-
What's Trending In The Biopharma And Biotech Industries
2/10/2023
With improved access to affordable digital technologies and a regulatory emphasis on diversity in patient recruitment, check out several highlights of the most notable projections in 2023.
-
Choosing A Digital Health Sensor Partner In Clinical Trials
10/22/2024
Explore what your organization should consider when selecting a digital health partner and monitoring solutions for your clinical trial.
-
Information Security Is Vital For Decentralized Trials
11/6/2023
Information is the most important currency to any business in the modern, highly tech driven world, and as a currency we should treat it with the utmost respect to avoid it being stolen, forged or devalued just like the money in your pocket. Learn what is crucial for data protection when running DCTs.
-
RBQM For Decentralized Trials: Two Key Areas Of Focus To Reduce Your Risk
9/26/2022
This article takes a more in-depth look at Sections 5.0.5: ‘Risk Communication’ and 5.0.6: ‘Risk Review.’ in ICH-GCP E6 R2 to show how the implementation of RBQM can reduce issues and achieve holistic trial oversight in today’s complex decentralized trials.
-
How “Future-Proof” Is Your Digital Biomarker Data?
3/5/2021
This white paper provides a comprehensive overview of wearable sensor data processing frameworks, traditional and emerging analytic methods, and how clinical trial sponsors will maximize their investment and ensure the long-term value of their digital biomarker data by selecting a wearable technology platform that collects and provides access to raw, “future-proof” source data.